ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
5,937.34
-0.21%
US Tech 100
20,478.00
-0.92%
Dow Jones
43,153.13
-0.16%
Brent Oil
80.475
-1.48%
Bitcoin
99,889.82
-0.63%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. Italy
  5. BIT

  6. Philogen Spa (PHIL) Quote

Philogen Spa

Philogen Spa (PHIL)

Pacific Horizon Investment Trust PLC
Pacific Horizon Investment Trust PLC
Pacific Horizon Investment Trust PLC
PHI Group Inc (PK)
18.60
0.10
(0.54%)
Closed January 16 11:30AM
Delayed by 15 minutes

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Key stats and details

Current Price
18.60
Bid
17.70
Ask
18.75
Volume
4,222
18.50 Day's Range 18.90
16.30 52 Week Range 21.90
Market Cap
751.395M
Previous Close
18.50
Open
18.55
Last Trade
1
@
18.6
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
4,874
Shares Outstanding
40,397,605
Dividend Yield
-
PE Ratio
0.00
Earnings Per Share (EPS)
-
Revenue
25.12M
Net Profit
-6.16M

About Philogen Spa

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.philogen.com
Headquarters
Siena, Siena, Ita
Founded
-
Philogen Spa is listed in the Pharmaceutical Preparations sector of the Italian Stock Exchange with ticker PHIL. The last closing price for Philogen was 18.50 €. Over the last year, Philogen shares have traded in a share price range of 16.30 € to 21.90 €.

Philogen currently has 40,397,605 shares outstanding. The market capitalization of Philogen is 747.36 € million.

Ask ADVFN Intelligence (AI)

PHIL Latest News

More News

Philogen provides update on pre-planned interim analysis of the Phase III FIBROSARC trial investigating Onfekafusp alfa (L19TNF) in patients with first-line advanced or metastatic Soft Tissue Sarcoma

Philogen provides update on pre-planned interim analysis of the Phase III FIBROSARC trial investigating Onfekafusp alfa (L19TNF) in patients with first-line advanced or metastatic Soft Tissue...

February 20 2024
GlobeNewswire Inc.

Philogen S.p.A. announces receipt of the Good Manufacturing Practice Certificate for its new Production facility in Rosia (Siena, Italy) by Competent Authorities

Philogen S.p.A. announces receipt of the Good Manufacturing Practice Certificate for its new Production facility in Rosia (Siena, Italy) by Competent Authorities SIENA, Italy, Dec. 05, 2023...

December 05 2023
GlobeNewswire Inc.

Philochem and Blue Earth Diagnostics Announce First Three Patients Imaged in Phase 1 Clinical Trial of 68Ga-OncoFAP (68Ga-OncoFAP-DOTAGA) for Diagnostic Imaging in Solid Tumors

Philochem and Blue Earth Diagnostics Announce First Three Patients Imaged in Phase 1 Clinical Trial of 68Ga-OncoFAP (68Ga-OncoFAP-DOTAGA) for Diagnostic Imaging in Solid Tumors Novel...

December 04 2023
GlobeNewswire Inc.

Nidlegy™ Phase III PIVOTAL trial meets the study’s primary objective demonstrating statistically significant and clinically meaningful improvement in Recurrence-Free Survival for patients with locally advanced fully resectable melanoma

Intratumoral Nidlegy™ followed by surgery significantly improved the Recurrence-Free Survival compared to surgery alone PIVOTAL (NCT02938299) is the first and so far only Phase III trial...

October 16 2023
GlobeNewswire Inc.

Philogen Announces Clinical Trial Collaboration with MSD

Philogen Announces Clinical Trial Collaboration with MSD The Phase II clinical trial investigates Philogen's immunocytokines (i) L19IL2 (ii) L19TNF, and (iii) Nidlegy™ in combination with...

June 01 2023
GlobeNewswire Inc.

Sun Pharma and Philogen enter into an Exclusive Distribution, License, and Supply Agreement for Commercializing specialty product, NIDLEGY™ in Europe, Australia and New Zealand

Sun Pharma and Philogen enter into an Exclusive Distribution, License, and Supply Agreement for Commercializing specialty product, NIDLEGY™ in Europe, Australia and New Zealand Mumbai...

May 30 2023
GlobeNewswire Inc.

Philogen Publishes New Data on a Fibromun-based treatment combination in Science Translational Medicine in collaboration with the University Hospital Zürich

Philogen Publishes New Data on a Fibromun-based treatment combination in Science Translational Medicine in collaboration with the University Hospital Zürich Philogen Publishes New Data on a...

May 25 2023
GlobeNewswire Inc.

Philogen Announces Publication of a New Study in Collaboration with Google focused on Machine Learning models applied to DNA-Encoded Chemical Library Technology

Philogen Announces Publication of a New Study in Collaboration with Google focused on Machine Learning models applied to DNA-Encoded Chemical Library Technology Philogen Announces Publication...

March 28 2023
GlobeNewswire Inc.

Philogen Provides Corporate Update

Philogen Provides Corporate Update Philogen Provides Corporate Update Nidlegy™ and Fibromun pivotal clinical trials on track Fibromun shows potent activity in last-line glioblastoma in...

December 01 2022
GlobeNewswire Inc.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.25-1.3262599469518.8518.918.4482618.61603813DE
40.10.54054054054118.519.7518.4423918.95530884DE
12-1.9-9.2682926829320.520.718.05487419.23859876DE
26-2.3-11.00478468920.921.918.05628919.96738014DE
521.16.2857142857117.521.916.3866419.06763497DE
1564.4831.728045325814.1221.913857916.91443903DE
2601.69.411764705881721.912.61204016.03089445DE

PHIL - Frequently Asked Questions (FAQ)

What is the current Philogen share price?
The current share price of Philogen is 18.60 €
How many Philogen shares are in issue?
Philogen has 40,397,605 shares in issue
What is the market cap of Philogen?
The market capitalisation of Philogen is EUR 747.36M
What is the 1 year trading range for Philogen share price?
Philogen has traded in the range of 16.30 € to 21.90 € during the past year
What is the reporting currency for Philogen?
Philogen reports financial results in EUR
What is the latest annual turnover for Philogen?
The latest annual turnover of Philogen is EUR 25.12M
What is the latest annual profit for Philogen?
The latest annual profit of Philogen is EUR -6.16M
What is the registered address of Philogen?
The registered address for Philogen is PIAZZA LA LIZZA, 7, SIENA, SIENA, 53100
What is the Philogen website address?
The website address for Philogen is www.philogen.com
Which industry sector does Philogen operate in?
Philogen operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
WCOP25Copernico Sim S.p.a
0.375 €
(50.00%)
84
WAAT26AA Tech SpA
0.06 €
(20.00%)
800
1BYNDBeyond Meat Inc
4.00 €
(18.91%)
396
MEVMevim SpA
0.64 €
(14.12%)
71.57k
NTWNetweek SpA
0.007 €
(12.90%)
1.43M
1VBKVerbio SE
8.38 €
(-22.91%)
178
BESBestbe Holding
0.524 €
(-22.02%)
235.36k
WUBM26Ulisse BioMed SpA
0.12 €
(-16.55%)
1.38k
WAMB26Ambromobiliare SpA
0.0431 €
(-15.82%)
15k
CNFConafi SpA
0.239 €
(-14.03%)
404.39k
TITTelecom Italia SpA
0.2591 €
(0.35%)
116.89M
ENELEnel Spa
7.086 €
(0.52%)
35.58M
TITRTelecom Italia
0.3034 €
(0.80%)
27.93M
ISPIntesa Sanpaolo Spa
4.099 €
(0.58%)
26.45M
BPEBper Banca SPA
6.418 €
(-0.65%)
18.67M

Discussion

View Full Feed
nilremerlin nilremerlin 2 minutes ago
50 dma still holding even at .61 above the 200 dma, the previous several days of price dip consolidation still confirming the integrity of the Golden Cross.
VWAP 3.06 US, Down today.
Close $3.06 US, Down today.
Volume was less than half the
10-day average volume today.
HITI
noradio noradio 3 minutes ago
What happened to the famous VeronicaFox/DJponder tag team duo? They both decided to put their altruistic days behind them? 🤣
navycmdr navycmdr 3 minutes ago
Alec Mazo on X ...

https://investorshub.advfn.com/uimage/uploads/2025/1/16/otmthAlec.JPG
FNMA
otterman otterman 3 minutes ago
TOI .48 +.08 +20% The chart is just getting to the powerzone.
TOI
fuagf fuagf 3 minutes ago
There is very little strictly original thought around these days. My woan instead of man=humanity could have been my best and it won't ever go anywhere .. lol .. https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174615625 .
SCAMBUSTERKING SCAMBUSTERKING 4 minutes ago
It's funny now no one cares about irrelevant Jakey. No one will buy his first share selling scam SONG, no one will buy this share selling SCAM either even if he got it trading. He has no clue what he is doing, he isn't getting it done, everything is way behind, and it seems everyone is a roadblock f
BCAP
baltimorebullet baltimorebullet 4 minutes ago
" the theory that because Anavex didn't go with the standard wall street financing that there hasn't been any push behind the stock"

I hold this truth to be self evident.
AVXL
Donotunderstand Donotunderstand 4 minutes ago
and was that 300B the value of the shares from warrants sold - which is 80% - as we own 20%

so increase that 300B by 25% (80 to 100 is a 25% increase) and its 375B

all big numbers
FNMA
rodeoup rodeoup 4 minutes ago
Wrong again and good luck with your agenda driven naysayers program. LOL!!!
NBRI
CrazyC CrazyC 4 minutes ago
FOXO - Shareholder vote tomorrow morning regarding the conversion of $23 million of their Series A Preferred Stock, most of which, is for the acquisition of Rennova Community Health, Inc. in 2024...

https://www.sec.gov/Archives/edgar/data/1812360/000149315225000409/formdef14a.htm
FOXO
glenn1919 glenn1919 4 minutes ago
VS.................................ENVB.............................................................................................a/h
ENVB
JMoneyHoops JMoneyHoops 5 minutes ago
They first need the 15-12G to become effective then it'll flip to Pink 
GXXM
ORCA ORCA 5 minutes ago
IF YOU LOOK AT THE HISTORICAL PRICES.THE AVERAGE VOLUMES WERE SMALL.YEAR AFTER YEAR
THE ONE YEAR HIGH WAS .036.THE 3 YEAR HIGH WAS .0895,AND THE 5 YEAR HIGH WAS .75.CRAZY
ANYONE THAT WILL SHORT THIS STOCK AFTER THE TODAYS NEWS.THEY WILL BE IN FOR A SERIOUS RUDE AWAKING.ON WATCH BIGLY F
GMER
Donotunderstand Donotunderstand 5 minutes ago
CBO showed a ton of values

e.g. from the prior page

If investors required a 10 percent return on their capital, they would value
the GSEs’ combined equity at $368 billion, CBO estimates

That is close to ACKMANS 300B
FNMA
TenKay TenKay 5 minutes ago
lol! I guess the Mullen “Strikingly Different” tours are truly over.

Nice find!
MULN
JTORENCE JTORENCE 6 minutes ago
RobotDroid "The saddest day in decades." Really, you are gone ,lefty.
NWBO
Investor2014 Investor2014 6 minutes ago
Yes in a biotech portfolio of great risk/reward stock picks the odds and return potential presented by $AVXL makes a good candidate constituent.
AVXL
noradio noradio 6 minutes ago
Can you imagine how many possible cures and therapeutics for terrible diseases have been destroyed by these psychopaths? Naked shorting is terrorism.
WHELANer WHELANer 6 minutes ago
Where did you find these predictions ? Are they your own ? The first month already looks like it could happen. Why do you have such a high PPS through the end of 2026 ?
AAPL
TTsr TTsr 7 minutes ago
Gettin real now! 

https://d18rn0p25nwr6d.cloudfront.net/CIK-0001390478/b344abf6-b5aa-4662-9d6b-71ad3b6abe1e.pdf
SLS
RichieBoy RichieBoy 7 minutes ago
Put into context on Daily Difficulties in 1 example.

This was actually discussed 4 months ago by the IT community. The degree of difficulty was further increased when the FBI finally had done there painstaking research on such a huge scope of the problem. Finally they could accurate
AFFU
stockrafter stockrafter 7 minutes ago
Keep up the good work PD96.......it's to unrewarding for this investor to answer bi1 endless questions, who will never answer yours, only more questions....

FTR posts are there just to point to when coming back to give the pleasure of saying, "Told ya."

Go Dr Torley....
HALO
12yearplan 12yearplan 7 minutes ago
True, there's a difference. A killing every five minutes for over an hour was a very good movie review comment from DD for my tastes but
BHawks counter was pretty good as well
https://upload.wikimedia.org/wikipedia/commons/thumb/8/80/Betty_Gilpin_by_Gage_Skidmore.jpg/330px-Betty_Gilpin
jeff66 jeff66 7 minutes ago
Yeah I seen it happening. Buying more as soon as it hits. Gonna be bigger than any of us can imagine I believe
TWOH
cadillacdave cadillacdave 7 minutes ago
Its nice to see Huang looking 30 years ahead, with his quantum day. We all know he wouldn't be hosting this event now, if the tech was truly 30 years away.
IONQ

Your Recent History

BIT
PHIL
Philogen
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads